Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Individuals with gastrointestinal issues: Gut health applications are supported by the peptide origin as a gastric protective compound
Notably, the target who lost weight and maintained it was rated more favorably (i.e., higher in positive traits, lower in negative traits, less unhealthy) than all three of the targets who currently had obesity (i.e., targets from the GLP-1 regain , diet+exercise regain , and no weight loss conditions), suggesting that having a higher weight is harshly stigmatized regardless of a persons prior weight loss attempts
Reason enough to bring the natural talent to general health awareness.
SPOTLIGHT The astounding rise of semaglutide and whats next for weight-loss drugs Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription $32.99 / 30 days cancel any time Subscribe to this journal Receive 52 print issues and online access $199.00 per year only $3.83 per issue Rent or buy this article Prices vary by article type from$1.95 to$39.95 Prices may be subject to local taxes which are calculated during checkout doi: This article is part of Nature Spotlight: Obesity, an editorially independent supplement
US$ 25.47
US$ 21.60
US$ 23.06
